首页>外文期刊>医学、药学、卫生>肿瘤学>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer

Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer

SCIMEDLINE

中文名称：胸肿瘤学杂志：国际肺癌研究协会的官方出版物

ISSN：1556-0864
出版周期：-

发文量：2468

期刊论文

热门论文

年度选择

2021
- 第1期
- 第2期
- 第3期
- 第4期
2020
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
2019
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2018
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2017
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2016
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2015
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
- 第1suppla期
2014
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2013
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2012
- 第1期
- 第2期
- 第3期
- 第4期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
- 第12suppla期
2011
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
- 第11suppla期
- 第7suppla期
2010
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
- 第10suppla期
2009
- 第1期
- 第2期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
2008
- 第1期
- 第3期
- 第4期
- 第5期
- 第6期
- 第7期
- 第8期
- 第9期
- 第10期
- 第11期
- 第12期
- 第6suppla期

更多>>

全选（0）

1.Caution Needed for Analyzing the Risks of Second Cancers

机译：谨慎分析第二种癌症的风险
- 作者：Summer S. Han;Sylvia K. Plevritis;Heather A. Wakelee
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第9期
2.MA16.10 Clinical Utility of Cerebrospinal Fluid Cell-Free DNA for Clarifying Genetic Features of Leptomeningeal Metastases in ALK Rearrangement NSCLC

机译：MA16.10脑脊液无细胞DNA的临床效用，用于澄清ALK重新排列NSCLC中睑作转移的遗传特征
- 作者：M. Zheng;Y. Li;B. Jiang;H. Tu;X. Zhang;J. Ye;W. Tang;S. Chuai;Y. Wu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
3.P2.09-18 A Clinicopathologic Analysis of Pulmonary Sclerosing Pneumocytoma in Korea : A Muticenter Study

机译：韩国肺硬化肺细胞瘤的临床病理分析：纯细胞研究
- 作者：S.Y. Ha;M.H. Kang;M.S. Roh;H.K. Kim;K.S.O.P. The Cardiopulmonary Pathology Study Group
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
4.MA03.01 Manchester Lung Cancer Screening: Results of the First Incidence Screening Round

机译：MA03.01曼彻斯特肺癌筛查：第一次发病率筛选的结果
- 作者：H. Balata;P. Crosbie;M. Evison;R. Booton
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
5.P1.01-111 EGFR exon20 Insertion Patients Treated with First-Line Chemotherapy in Non-Small Cell Lung Cancer

机译：P1.01-111 EGFR EXON20插入患者在非小细胞肺癌中用一线化疗治疗
- 作者：C. Zhao;X. Li;C. Su;X. Chen;S. Ren;C. Zhou
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
6.MA24.03 Biologic Profiling of Pre-Metastatic Niche in Completely Resected Pathological Stage I Non-Small Cell Lung Cancer

机译：MA24.03在完全切除的病理学阶段I中的转移性地素的生物谱分析I非小细胞肺癌
- 作者：T. Saito;H. Ryota;M. Ishida;K. Fukumoto;H. Matsui;Y. Taniguchi;H. Yanagimoto;K. Tsuta;T. Murakawa
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
7.P2.09-30 Clinicopathological Investigation of Four Resected Cases for Pleomorphic Carcinoma of the Lung

机译：P2.09-30肺部肺炎术治疗四种切除病例的临床病理调查
- 作者：K. Taguchi;H. Inoue;O. Kawamata
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
8.P2.17-30 Serum Lipoprotein(A) Correlates with the Effect of Endostar Combined with Concurrent Chemoradiotherapy in Patients with Locally Advanced LSCC

机译：P2.17-30血清脂蛋白（A）与近期LSCC患者联合同时进行化学疗法的肺结泡联合的效果相关
- 作者：H. Yang;M. Wang;B. Wang;X. Wu;W. Wang;C. Zhou;D. Lv;F. Kong
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
9.P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib

机译：用Osimertinib治疗的晚期非小细胞肺癌患者胃肠道和肝毒性的风险
- 作者：K. Thein;S. Swarup;S. Ball;M. Quirch;Y. Vorakunthada;S. Khan;F. Hardwicke;S. Awasthi;L. Tijani
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
10.P2.16-28 Comparison of Outcomes of VATS Segmentectomy Versus Lobectomy for Non-Small Cell Lung Cancer Using a Propensity Score Matching Analysis

机译：P2.16-28使用倾向评分匹配分析比较非小细胞肺癌的VATS细胞切除术的结果与肺切除术
- 作者：Y. Hwang;K. Hyun;S. Park;H.J. Lee;I.K. Park;Y. Kim;C.H. Kang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
11.P2.04-29 Preliminary Results With Tislelizumab in Chinese Patients With Non-Small Cell Lung Cancer (NSCLC)

机译：P2.04-29与中国非小细胞肺癌患者的Tislelizumab初步结果（NSCLC）
- 作者：Y. Wu;J. Zhao;Q. Zhang;H. Pan;J. Wang;Y. Bai;J. Li;Z. Wang;C. Wei;X. Li;Q. Zhou
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
12.P3.03-16 3D Morphometric Detection of Mismatch Repair Deficiency in Human Lung Adenocarcinoma Cell Lines using the Cell-CT? Platform

机译：P3.03-16使用细胞-CT的人肺腺癌细胞不匹配修复缺陷的3D形态学检测吗？平台
- 作者：D. Sussman;L. Kelbauskas;M. Meyer;R. Katdare;A. Nelson
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
13.P2.15-01 CANscript? as a Patient-Derived Predictive Platform for individualizing Treatment in Lung Cancer

机译：p2.15-01刀具呢？作为肺癌中个体化治疗的患者衍生的预测性平台
- 作者：K.G. Babu;D. K;B. Balakrishnan;M. Biswas;A. Prasath;P. Radhakrishnan;A. Chatterjee;S. Thyiagarajan;P. Chaudhury
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
14.Meeting Announcements

机译：会议公告
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第8期
15.P2.03-16 TGF-β Induced EMT and Stemness Characteristics are Associated with Epigenetic Regulation in Lung Cancer

机译：P2.03-16 TGF-β诱导的EMT和茎秆特征与肺癌的表观遗传调节有关
- 作者：S.J. Kim;N. Kang;B.N. Kim;C.K. Park;Y.K. Kim
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
16.P2.12-01 Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study

机译：BENOTECAN作为反复性小细胞肺癌的二线治疗的疗效：IIB随机多中心研究
- 作者：J. Kang;K.H. Lee;D. Kim;S. Kim;H.R. Kim;J.H. Choi;H.J. An;J. Kim;J.S. Jang;B. Kim;H.T. Kim
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
17.P1.16-55 Surgical Treatment for Lung Cancer. Subaortic (Para-Aortic) Lymph Nodes Involvement - N1 or N2 Disease?

机译：P1.16-55肺癌外科治疗。 subaoric（para-主动脉）淋巴结参与 - n1或n2疾病？
- 作者：M. Szcz?sna;P. Rudzinski;T. Or?owski
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
18.P3.04-23 Phase 1b/2 Study to Evaluate Novel Combinations With Oleclumab (MEDI9447) in Previously Treated Advanced EGFRm NSCLC

机译：P3.04-23期1B / 2研究以评估在先前治疗的高级EGFRM NSCLC中与Oleclumab（Medi9447）的新组合
- 作者：N. Rizvi;C. Shu;S. Goldberg;V. Papadimitrakopoulou;D.R. Camidge;S. Patel;K. Marrone;S. Kim;D. Kim;H. Hsieh;N. Mueller;R. Kumar;J. Englert;K. Park
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
19.P3.CR-33 Trichoptysis, Hemoptysis and Chest Pain: A Very Rare Presentation of Anterior Mediastinal Teratoma in a Young Patient

机译：p3.cr-33 richoptysis，咯血和胸痛：年轻患者中纵隔畸胎瘤的一个非常罕见的介绍
- 作者：A. Saidane;B. Dhahri;H. Cherif;H. Aouina
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
20.Radiologic Pseudoprogression during Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

机译：抗PD-1治疗期间的放射学假罗竞争为先进的非小细胞肺癌
- 作者：Sharyn I. Katz;Mark Hammer;Stephen J. Bagley;Charu Aggarwal;Joshua M. Bauml;Jeffrey C. Thompson;Arun C. Nachiappan;Charles B. Simone;Corey J. Langer
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第7期
- Anti–PD-1 therapy;
- NSCLC;
- Immune-related response criteria;
- Pseudoprogression;
21.P3.15-08 Patient-Reported Outcomes (PROs) in Patients with Lung Resection: Open Versus Minimal Invasive Surgery

机译：P3.15-08肺部切除患者的患者报告的结果（优点）：开放与最小侵入性手术
- 作者：W. Dai;Q. Shi;X. Peng;X. Yang;Q. Li
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
22.P2.12-17 Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement

机译：P2.12-17预防性颅辐射不能为没有淋巴结受累的切除小细胞肺癌提供生存益处
- 作者：B. Han;J. Xu;R. Qiao;J. Teng;B. Zhang;S. Wang;J. Qian;Y. Lou;Y. Zhang;X. Zhang;X. Fu;T. Chu;H. Zhong
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
23.MA21.06 Proteins Associated with Survival Differ Depending on Molecular Subtypes, and Mutational- and Smoking-Status In NSCLC Biopsies

机译：与生存相关的MA21.06蛋白质取决于分子亚型，并且在NSCLC活检中的突变和吸烟状态不同
- 作者：A. Halvorsen;M. Haugen;?. ?jlert;S. Solberg;L. J?rgensen;G. M?landsmo;O. Brustugun;?. Helland
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
24.P3.13-24 Efficacy of EGFR-TKIs Compared with Chemotherapy as First-Line Therapy in Patients with EGFR Rare Mutation Advanced Lung Adenocarcinoma

机译：EGFR-TKI的疗效与化疗相比，EGFR稀有突变晚期肺癌患者的一线治疗
- 作者：H. Wang;H. Li;M. Zhang;G. Zhang;X. Zhang;Z. Ma
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
25.MA07.07 Identifying the Severity of Psychosocial Symptoms Among Patients Diagnosed with Lung Cancer. Do We Really Need Emotional Support Groups?

机译：MA07.07鉴定患有肺癌的患者心理社会症状的严重程度。我们真的需要情绪支持群体吗？
- 作者：A. Fatima;S.S.A. Zaidi
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
26.OA02.07 Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer

机译：OA02.07更新结果1阶段的DS-8201A在HER2-表达或 - 矫正前的非小细胞肺癌中的研究结果
- 作者：J. Tsurutani;H. Park;T. Doi;S. Modi;S. Takahashi;K. Nakagawa;I. Krop;S. Waqar;K. Yoh;B. Li;S. Taira;T. Jikoh;J. Singh;M. Sugihara;P. J?nne
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
27.P1.01-16 First-Line Pembrolizumab With or Without Chemotherapy in PD-L1 positive NSCLC: A Network Meta-Analysis of Randomized Trials

机译：P1.01-16 PD-L1阳性NSCLC中有或没有化疗的一线Pembrolizumab：随机试验的网络荟萃分析
- 作者：M. Doherty;S. Delos Santos;A. Putri Rahmadian;K. Chan
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
28.P1.13-37 Clinical Evaluation of Plasma-Based (cfDNA) Genomic Profiling in Over 1,000 Patients with Advanced Non-Small Cell Lung Cancer

机译：P1.13-37在1,000名晚期非小细胞肺癌患者中基于血浆（CFDNA）基因组分析的临床评价
- 作者：H. Tran;V. Lam;M. Vasquez;L. Hong;R. Colen;N. Elshafeey;I. Hassan;E. Prado;V. Papadimitrakopoulou;G. Blumenschein;B. Carter;G. Simon;L. Byers;M. Altan;Y. Elamin;R. Lanman;V. Raymond;A. Tsao;D. Gibbons;F. Fossella;J. Zhang;J. Heymach
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
29.Bilateral Vocal Cord Paralysis: Pembrolizumab-Induced Delayed-Onset Toxicity in a Patient with Lung Adenocarcinoma

机译：双侧声带瘫痪：Pembrolizumab诱导肺腺癌患者延迟发作的毒性
- 作者：Satoshi Hamada;Natsumi Okamoto;Mitsuhiro Tsukino
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第12期
30.P3.CR-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report

机译：P3.CR-11 ROS1融合和肺部腺癌中的扩增双重驱动伴侣共存，对克里齐尼尼的反应：案例报告
- 作者：C. Xu;W. Wang;Z. Song;Q. Zhang;W. Zhuang;Y. Chen;G. Chen;M. Fang;T. Lv;Y. Song
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
31.Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

机译：通过液体活组织检查检测到肺癌患者的双颅杆菌和Osimertinib治疗的反应，液体活组织检查获得次级抗EGFR酪氨酸激酶抑制作用
- 作者：Lei Deng;Lesli A. Kiedrowski;Elizabeth Ravera;Haiying Cheng;Balazs Halmos
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第9期
32.ES03.01 Diagnosis of Mesothelioma Based on Cytology Alone

机译：ES03.01仅基于细胞学的间皮瘤诊断
- 作者：J. Sauter
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
33.P1.09-10 Targeted Sequencing of Pulmonary Enteric Adenocarcinoma Reveals Distinctive Mutation Profile from Conventional Type of Lung Adenocarcinoma

机译：P1.09-10肺肠腺癌的靶向测序揭示了来自常规类型的肺腺癌的独特突变谱
- 作者：L. Hou;C. Wu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
34.P3.16-33 Characteristics and Risk Factors of Recurrence After Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer

机译：P3.16-33临床阶段患者临床切除术后复发性的特征及风险因素I非小细胞肺癌
- 作者：A. Nakamura;Y. Shimizu;T. Goto;S. Sato;T. Koike;M. Tsuchida
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
35.P2.01-93 The Analysis of the Soluble Programmed Death-1 of Lung Cancer Patients with Different Characteristics

机译：p2.01-93肺癌患者可溶性编程死亡1分析不同特征的分析
- 作者：H. Zhu;R. Tian;W. Guo;Y. Guo;J. Xu;X. Song
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
36.JCSE01.22 Differential Molecular Mechanisms Associated with Dramatic and Gradual Progression in NSCLC Patients with Intrathoracic Dissemination

机译：JCSE01.22与NSCLC患者肺听诊患者戏剧性和逐渐进展相关的差分分子机制
- 作者：Y. Chen;B. Hua;W. Li;C. Zhang;W. Tang;A. Wang;X. Wu;J. Chen;J. Su;Y.W. Shao;Y. Wu;W. Zhong
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
37.P1.03-14 Interaction Between Celecoxib and Cisplatin is Dependent on The p53 Status in Human NSCLC Cell Lines

机译：Celecoxib和顺铂之间的相互作用取决于人NSCLC细胞系中的P53状态
- 作者：M. Jiang;W. Li;L. Ma;L. Zhang;J. Tan;S. Zheng;Y. Liu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
38.MA08.06 Outcomes Among Patients with EGFR-Mutant Metastatic NSCLC with and without Brain Metastases

机译：EGFR-突变体转移性NSCLC患者的结果，没有脑转移的患者
- 作者：E. Nadler;M. Pavilack;J. Espirito;B. Baidoo;A. Fernandes
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
39.P2.16-37 The Introduction of Robotic Lobectomy for Non-Small Cell Lung Cancer in South East Asia: A 5-Year Single Centre Study

机译：P2.16-37东南亚非小细胞肺癌机器人肺病的引入：一个5年的单中心研究
- 作者：K. Ong;A.A. Fazuludeen;D. Aneez
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
40.P2.04-01 Associations Histological Subtype of Lung Adenocarcinoma and Programmed Death Ligand 1 (PD-L1) Expression in Tumor Cells.

机译：P2.04-01肿瘤细胞中肺腺癌和编程死亡配体1（PD-L1）表达的组织学亚型。
- 作者：G. Cruz-Rico;X. Popa Navarro;A. Avilés-Salas;K.Y. Flores-Vélez;A. Cardona;L. Ramírez-Tirado;E. Vergara;F. Barron;L.A. Cabrera-Miranda;O. Arrieta
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
41.P3.01-25 Feasibility of Moderate Hypofractionated Thoracic Irradiation for Non-Small Cell Lung Cancer Patients with Very Limited Lung Function

机译：P3.01-25非小细胞肺癌肺功能患者适度低渗胸辐射的可行性
- 作者：F. Manapov;O. Roengvoraphoj;J. Taugner;M. Dantes;L. K?smann;C. Wijaya;N. Schmidt-Hegemann;C. Belka;C. Eze
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
42.P2.03-17 EGFR T790M Mutation may not be Generated through Selection by EGFR-TKI from Randomly Occurring Mutations in Vitro Using ENU

机译：通过EGFR-TKI从使用ENU中的体外随机发生的突变，可以通过选择来产生P2.03-17 EGFR T790M突变
- 作者：Y. Kobayashi;T. Mitsudomi
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
43.P2.06-18 Comparison of Extubation Time of Pleulectomy/Decortication with Lobectomy Under General Anesthesia Using Desflurane

机译：P2.06-18使用DesfluRane在全身麻醉下的肺切除术/抗切除术/抗伤术的拔管时间比较
- 作者：K. Kawata;N. Funatsu;H. Tao;K. Okabe
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
44.A Longitudinal Investigation of Internalized Stigma, Constrained Disclosure, and Quality of Life Across 12 Weeks in Lung Cancer Patients on Active Oncologic Treatment

机译：在活性肿瘤治疗肺癌患者12周内对内化耻辱，约束披露和生活质量的纵向调查
- 作者：Timothy J. Williamson;Alyssa K. Choi;Julie C. Kim;Edward B. Garon;Jenessa R. Shapiro;Michael R. Irwin;Jonathan W. Goldman;Krikor Bornyazan;James M. Carroll;Annette L. Stanton
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第9期
- Lung cancer;
- Stigma;
- Disclosure;
- Quality of life;
- Well-being;
- Longitudinal;
45.P1.13-29 Overall Response Rate of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC

机译：P1.13-29 Nintedanib和Docetaxel的总体反应率与Advanced NSCLC中硅蛋白的营养用途相结合
- 作者：J. Bosch Barrera;J.C. Ruffinelli;E. Carcereny;E. Sais;S. Verdura;E. Cuyàs;R. Palmero;A. Izquierdo;T. Morán;E. Nadal;J.A. Menéndez
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
46.P3.04-20 Correlation of Immune-Related Adverse Events and Response from Immune Checkpoint Inhibitors in Patients with Advanced NSCLC

机译：P3.04-20免疫相关不良事件的相关性和免疫检查点抑制剂在高级NSCLC患者中的反应
- 作者：M. Sung;A. Zer;P. Walia;L. Khoja;M. Maganti;C. Labbe;F. Shepherd;P. Bradbury;G. Liu;N. Leighl
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
47.P1.05-20 Therapeutic Condition of Photodynamic Therapy Using Taraporfin Sodium for Central Airway Stenosis

机译：用塔 - 氨基钠对中心气道狭窄的光动力疗法治疗条件
- 作者：T. Tsuchida;Y. Matsumoto;M. Tanaka
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
48.Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program

机译：AFATINIB在重预处理患者的ARBB2突变阳性高级NSCLC中的活动：来自全球名为患者使用程序的调查结果
- 作者：Solange Peters;Alessandra Curioni-Fontecedro;Hovav Nechushtan;Jin-Yuan Shih;Wei-Yu Liao;Oliver Gautschi;Vito Spataro;Mojca Unk;James Chih-Hsin Yang;Robert M. Lorence;Philippe Carrière;Agnieszka Cseh;Gee-Chen Chang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第12期
- Afatinib;
- NSCLC;
- ERBB2mutation;
49.P2.06-01 Short-Term Outcome of Entire Pleural Intensity-Modulated Radiotherapy in a Neoadjuvant Setting for Malignant Mesothelioma

机译：P2.06-01对恶性间皮瘤的新辅助环境中整个胸膜强度调节放射疗法的短期结果
- 作者：J.H. Hong;Y.S. Kim;S.J. Kim;S. Hong;K.S. Kim;S.W. Moon
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
50.OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403

机译：OA10.04 AFATINIB有或没有Cetuximab用于EGFR-突变体非小细胞肺癌：SWOG S1403的安全性和功效结果
- 作者：S. Goldberg;M. Redman;R. Lilenbaum;K. Politi;T. Stinchcombe;L. Horn;E. Chen;S. Mashru;S. Gettinger;M.A. Melnick;J. Miao;J. Moon;K. Kelly;D. Gandara
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
51.P3.11-09 Shared Decision Making; A Decision Aid for the Primary Practitioner

机译：P3.11-09共享决策; 对主要从业者的决策援助
- 作者：F. Grannis
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
52.OA10.01 Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC

机译：OA10.01患者偏偏东酪氨酸激酶抑制剂治疗EGFR突变阳性转移性NSCLC
- 作者：J. Bridges;M. De La Cruz;M. Pavilack;E. Flood;E. Janssen;N. Chehab;A. Fernandes
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
53.P2.17-12 Eliminating Radiation Resistance of Non-Small Cell Lung Cancer By DHA Trough Abrogating Immunity Escaping via Inhibiting PD-L1 Expression

机译：P2.17-12通过抑制PD-L1表达，消除了DHA槽的非小细胞肺癌的抗辐射抗性免疫力逸出
- 作者：X. Gong;X. Li;Y. Xu;C. Zhou
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
54.MS05.03 Tumor Heterogeneity in Lung Cancer

机译：MS05.03肺癌肿瘤异质性
- 作者：E. Brambilla
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
55.MA06.05 The Micro-Environmental Cross Talk Between Mast Cells and Lung Cancer Cells Through Cell-to-Cell Contact

机译：MA06.05通过细胞至细胞接触肥大细胞和肺癌细胞之间的微环境交叉
- 作者：R. Shemesh;Y. Gorzalczany;S. Geva;L. Roisman;R. Sagi-Eisenberg;N. Peled
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
56.P3.15-11 Association Between Peripheral Blood Ratios and Clinical Stage Disease in Lung Cancer.

机译：肺癌外周血血液比率与临床阶段病的关联P3.15-11。
- 作者：C. Flores;D. Enriquez;A. Aguilar;L.A. Mas Lopez;C. Vallejos
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
57.ES06.02 Integrating New Systemic Therapy into Trials in OMD

机译：ES06.02将新的全身疗法整合到OMD中的试验中
- 作者：S. Popat
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
58.P1.17-04 Curative Intent Treatment for Stage III NSCLC in England

机译：P1.17-04英格兰阶段III NSCLC治疗意图治疗
- 作者：S. Harden;A. Khakwani;P. Beckett;J.B. Adizie
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
59.Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

机译：在预期期II试验中治疗的同步寡聚蛋白的NSCLC患者超过5年的无进展生存和整体存活率（NCT 01282450）
- 作者：Dirk De Ruysscher;Rinus Wanders;Lizza E. Hendriks;Angela van Baardwijk;Bart Reymen;Ruud Houben;Gerben Bootsma;Cordula Pitz;Linda van Eijsden;Anne-Marie C. Dingemans
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第12期
- Non-small cell lung cancer;
- oligometastases;
- long-term survival;
- phase II trial;
60.P1.16-23 Long-Term Survival Analysis of Surgery in Potential Stereotactic Ablative Radiotherapy Candidates of Non-Small Cell Lung Cancer

机译：P1.16-23非小细胞肺癌潜在立体定向烧蚀放疗患者的手术长期存活分析
- 作者：S. Li;S. Zhang;Y. Ma;Y. Yang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
61.P3.01-60 A Novel MET D1246H Mutation After Progression of EGFR-TKI/MET Inhibitor Combined Therapy in a NSCLC Patient with Acquired MET Amplification

机译：P3.01-60在NSCLC患者中获得EGFR-TKI / MET抑制剂联合治疗后的新型MET D1246H突变，获得达到普及扩增
- 作者：Y. Liang;Q. Chen;Y. Lin;H. Liu;B. Qiu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
62.MA25.07 Effectiveness of Systemic Therapy Combined with Thoracic Radiotherapy for Patients with Oligometastatic NSCLC: A Pooled Analysis

机译：MA25.07系统治疗的有效性联合胸腔放射治疗寡核症NSCLC的患者：汇总分析
- 作者：J. Wang;X. Lu;L. Wang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
63.P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients

机译：P2.01-12 Ramucirumab + Docetaxel在现实世界先进的非小细胞肺癌患者中快速疾病进展之后
- 作者：M. Batus;C. Molife;J. Clarke;V. Stefaniak;K. Winfree;Z. Cui;Y. Han;M. Tawney;P. Bonomi
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
64.P2.03-14 PKCi-PAK1 Pathway Modulates Sensitivity to Therapy in EGFR, KRAS Mutant and Squamous Cell Non-Small Cell Lung Cancer (NSCLC)

机译：PKCI-PAK1 PKCI-PAK1途径调节EGFR，KRAS突变体和鳞状细胞非小细胞肺癌（NSCLC）的敏感性
- 作者：M. Ito;C. Codony-Servat;J. Codony-Servat;I. Attili;J. Berenguer;J. Bracht;N. Gil;M. Okada;N. Karachaliou;P. Cao;R. Rosell
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
65.Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1–Expressing Non–Small Cell Lung Cancer

机译：在PEMBROLIZUMAB单药治疗的非小细胞肺癌中，疾病应对铂基化学疗法添加到PEMBROLIZUMAB之后
- 作者：Christine A. Garcia;Sanja Dacic;Liza C. Villaruz
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第8期
66.P1.04-28 Baseline Markers of Inflammation and Outcome with Nivolumab in Pretreated Non Small Cell Lung Cancers: A Retrospective Study

机译：P1.04-28预处理非小细胞肺癌中Nivolumab的炎症和结果的基线标志：回顾性研究
- 作者：A. Russo;A. Battaglia;G. Provazza;G. Lo Certo;G. Ricciardi;M. Picciotto;A. Scimone;G. Toscano;V. Adamo;T. Franchina
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
67.P3.04-03 Association of Functional Polymorphism in CTLA-4 Gene with Survival in Non-Small Cell Lung Cancer: A Brazilian Study

机译：P3.04-03非小细胞肺癌中CTLA-4基因功能多态性的关联：巴西研究
- 作者：J. Machado-Rugolo;A. Fabro;E. Cuentas;V. De Sá;C. Rainho;M. Nagai;V. Capelozzi;M. Balancin
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
68.GR01.02 Surgical Oncology

机译：GR01.02外科肿瘤学
- 作者：P.L. Filosso;E. Ruffini;F. Guerrera;P. Lausi;P. Lyberis;A. Oliaro
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
69.OA09.07 Association Between Outdoor Air Pollution And Lung Cancer in Female Never Smokers

机译：OA09.07女性在女性中的室外空气污染和肺癌之间的关联从不吸烟
- 作者：R. Myers;M. Brauer;S. Ladhar;S. Atkar-Khattra;J. Yee;C. Ho;A. Mcguire;K. Grant;A. Lee;B. Melosky;S. Sun;M. Tammem?gi;S. Lam
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
70.P2.12-10 Novel Prognostic Model for Limited-Stage Small-Cell Lung Cancer

机译：P2.12-10有限阶段小细胞肺癌的新型预后模型
- 作者：H. Chen;A. Warner;E. Ali;G. Rodrigues;A. Louie
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
71.MA12.06 STELLAR – Final Results of a Phase 2 Trial of TTFields with Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma

机译：MA12.06恒星 - 具有化疗的TTFIELS的2阶段试验的最终结果，用于一线治疗恶性胸膜间皮瘤
- 作者：G. Ceresoli;J. Aerts;J. Madrzak;R. Dziadziuszko;R. Ramlau;S. Cedres;B. Hiddinga;J. Van Meerbeeck;M. Mencoboni;D. Planchard;A. Chella;L. Crinò;M. Krzakowski;F. Grosso
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
72.P2.13-43 Phase 1 Study of the Anti-HER3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC

机译：P2.13-43期1研究抗HER3抗体药物缀合物U3-1402在转移或不可切除的EGFR-突变体NSCLC中
- 作者：P. J?nne;H. Yu;M. Johnson;C. Steuer;M. Vigliotti;N. Shipitofsky;F.M. Guevara;S. Chen;C. Yu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
73.P3.01-59 Comparison of Lobectomy, Segmentectomy and Wedge Resection for Early Stage NSCLC: A Direct and Network Meta-Analysis

机译：P3.01-59早期NSCLC术后，分段切除术和楔切除术的比较：直接和网络荟萃分析
- 作者：W. Liang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
74.P1.09-38 Pulmonary Epithelioid Hemangioendothelioma (EHE) with Von Recklinghausen Disease

机译：P1.09-38肺上皮细胞血管瘤（婚姻）通过雷克林豪森病
- 作者：S. Yamamoto;M. Kuwahara
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
75.P2.11-20 Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer

机译：P2.11-20肺部综合TM - 基于甲基化的血液检测的培训和试验组的研究结果
- 作者：J. Chorostowska-Wynimko;I. Horváth;D. Shitrit;V. Eisenberg;D. Stav;D. Levy Faber;P. Rudzinski;M. Jansen;Y. Raviv;V. Panagoulias;G. Izbicki;O. Ronen;A. Goldhaber;R. Moalem;N. Arber;R. Shahien;I. Haas;M. Gaga
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
76.Checkpoint Inhibitor Pneumonitis — Real-World Incidence and Risk

机译：检查点抑制剂肺炎 - 现实世界的发病率和风险
- 作者：Rebecca Y. Tay;Raffaele Califano
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第12期
77.P3.03-28 LKB1 Mutation Status is Associated with Poor Radiation Outcome in Patients with Non-Small Cell Lung Cancer

机译：P3.03-28 LKB1突变状态与非小细胞肺癌患者的辐射结果差有关
- 作者：P. Sitthideatphaiboon;A. Cobo;A. Poteete;F. Zhang;D. Lui;W. Rinsurongkawong;J. Heymach
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
78.P1.16-01 Prognostic Variables Associated with Improved Outcomes in Stage III NSCLC Patients Treated with Consolidation Pembrolizumab

机译：P1.16-01与巩固彭布罗齐押治疗的III阶段NSCLC患者改善结果相关的预后变量
- 作者：B. Anouti;S. Althouse;G. Durm;T. Breen;N. Hanna
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
79.P2.03-27 Polymorphisms in Folate Metabolism Related Genes Affect the Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer

机译：P2.03-27叶酸新陈代谢相关基因的多态性影响早期非小细胞肺癌的存活结果
- 作者：S.H. Choi;S.K. Do;J.E. Choi;S.S. Yoo;S.Y. Lee;J.Y. Park
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
80.MA16.04 Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations

机译：MA16.04具有同时TP53和RB1突变的EGFR突变体肺癌的临床和分子特征
- 作者：M. Offin;M. Tenet;R. Shen;N. Rekhtman;H. Rizvi;M. Hellmann;M. Arcila;M. Ladanyi;C. Rudin;M. Kris;H. Yu
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
81.P32 Identification of EGFR Mutational Profile in Lung Cancer Moroccan Patients Using ARMS Technology

机译：P32使用武器技术的肺癌摩洛哥患者EGFR突变谱的鉴定
- 作者：H. Kaanane;H. El Atar;L. Badre;A. Louahabi;I. Casa;S. Nadifi
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第9期
82.MS21.06 Immunotherapy - Sequence or Combination?

机译：MS21.06免疫疗法 - 序列或组合？
- 作者：R. Herbst
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
83.Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer

机译：更新的疗效分析，包括橡树的次要人口结果：患有先前治疗的晚期非小细胞肺癌患者的atezolizumab与多西紫杉醇的随机期III研究
- 作者：Louis Fehrenbacher;Joachim von Pawel;Keunchil Park;Achim Rittmeyer;David R. Gandara;Santiago Ponce Aix;Ji-Youn Han;Shirish M. Gadgeel;Toyoaki Hida;Diego L. Cortinovis;Manuel Cobo;Dariusz M. Kowalski;Filippo De Marinis;Mayank Gandhi;Bradford Danner;Christina Matheny;Marcin Kowanetz;Pei He;Federico Felizzi;Hina Patel;Alan Sandler;Marcus Ballinger;Fabrice Barlesi
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第8期
- Atezolizumab;
- PD-L1;
- Checkpoint inhibitor;
- Non–small cell lung cancer;
- Cancer immunotherapy;
84.P1.03-22 MiR-125b Plays a Tumor Suppressor Role in Inflammation-Related Non-Small Cell Lung Cancer via Repressing IGF-1 Signal Pathway

机译：P1.03-22 MIR-125B通过抑制IGF-1信号途径在炎症相关的非小细胞肺癌中起肿瘤抑制作用作用
- 作者：Y. Zhang;Y. Lou;B. Sun;X. Zhang;B. Han
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
85.P2.06-36 EORTC 1205: Randomized Phase II Study of Pleurectomy/Decortication Preceded or Followed by Chemotherapy in Early Stage MPM

机译：P2.06-36 EORTC 1205：随机期II在早期MPM中进行胸膜切除术/凝固性的研究
- 作者：J. Raskin;V. Surmont;B. Hasan;E. De Maio;P. Van Schil;J. Van Meerbeeck
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
86.Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations

机译：用双G719S和S768I EGFR突变肺腺癌患者酪氨酸激酶抑制作用
- 作者：Jacob Zaemes;Richard D. Hall;Ryan D. Gentzler
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第8期
87.P1.04-32 Phase I/II Study of the A2AR Antagonist NIR178 (PBF-509), an Oral Immunotherapy, in Patients (pts) with Advanced NSCLC

机译：A2AR拮抗剂NIR178（PBF-509），口服免疫疗法，患者（PTS），具有先进的NSCLC的P1.04-32研究
- 作者：A. Chiappori;C. Williams;B. Creelan;T. Tanvetyanon;J. Gray;E. Haura;D.T. Chen;R. Thapa;A. Beg;T. Boyle;M. Sangani;E. Morris;A. Tao;F. Hurtado;L. Manenti;J. Castro;S. Antonia
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
88.PC05.04 Debate 2: Patient Reported Outcomes Should Be the Most Important Endpoint in Trials in the Palliative Setting - YES

机译：PC05.04辩论2：患者报告的结果应该是姑息地区试验中最重要的终点 - 是的
- 作者：M. Pérol
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
89.P2.13-33 A Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient with NRAS Mutation Positive NSCLC

机译：P2.13-33患有NRAS突变阳性NSCLC患者MEK抑制的特殊临床反应的病例报告
- 作者：M. Krebs;D. Graham;M. Ayub;J. Dransfield;H. Frost;S. Aruketty;B. Kilerci;A. Wallace;R. Kamboj;D. Bakhle;V. Palle;S. Sharma;N. Maharaj;R. Kumawat;M. Bhonde;K. Frese;C. Dive;D. Rothwell;G. Brady
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
90.In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee

机译：在这个问题/研究手表/从IASLC烟草控制委员会的新闻报道/新闻
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第11期
91.Minimal Change Disease Induced by Lorlatinib

机译：Lorlatinib诱导的最小变化疾病
- 作者：Maureen Betton;Valérie Gounant;Aurélie Sannier;Guillaume Hanouna;Jean-Michel Goujon;Solenn Brosseau;Gérard Zalcman;Jonathan M. Chemouny
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第8期
92.P1.01-99 Detecting HER2 Alterations by Next Generation Sequencing (NGS) in Patients with Advanced NSCLC from the United States and China

机译：P1.01-99在美国和中国的高级NSCLC患者中检测到下一代测序（NGS）的HER2改变
- 作者：C. Xu;Y. Zhang;D. Liu;R. Shen;P. Razavi;S. Liu;H. Sun;M. Offin;A. Drilon;C. Rudin;M. Arcila;Y. Wu;B. Li
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
93.P1.04-14 HLA B44 Supertype Associated with Less Favorable Neoantigen Binding in Non-Small Cell Lung Cancer Treated with Immunotherapy

机译：P1.04-14 HLA B44超型与免疫疗法处理的非小细胞肺癌中的不利新尼奥登结合相关
- 作者：A. Cummings;H. Lu;J. Gukasyan;J. Madrigal;J. Carroll;K. Bornazyan;B. Jones;Z. Noor;A. Lisberg;J.W. Goldman;S. Hu-Lieskovan;S. Dubinett;E. Garon
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
94.Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding

机译：在编程死亡 - 1抑制剂治疗期间动脉栓塞：意外发现
- 作者：Filippo Gustavo Dall’Olio;Francesca Sperandi;Karim Rihawi;Mauro Gargiulo;Barbara Melotti;Stefano Brocchi;Francesco Gelsomino;Andrea Ardizzoni
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第12期
95.P1.14-05 The Association of Pulmonary Function with Survival After Treatment in Patients with Esophageal Cancer

机译：P1.14-05食管癌患者治疗后肺功能与存活的关联
- 作者：H. Liao;P. Yang;J. Lee
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
96.P3.13-21 Apatinib Plus Icotinib as First-Line Therapy For EGFR Co-Mutations NSCLC in Chinese Patients: An Exploratory Study

机译：P3.13-21 apatinib加icotinib作为中国患者EGFR共衰脱NSCLC的一线治疗：探索性研究
- 作者：Y. Shang;X. Li;R. Huo;M. Ji;Z. Song;B. Liu;Y. Jia;Y. Li;J. Jiao;J. Shi;Y. Zhang;X. Chen;M. Yao;X. Zhang;A. Zang
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
97.P1.04-16 Comparison of Clinical Response to Checkpoint Inhibitors in Advanced NSCLC with High PD-L1 Expression Tested on Cytology Versus Biopsy Samples

机译：P1.04-16具有高PD-L1表达对细胞学性的高PD-L1表达的临床响应对检查点抑制剂的比较和活组织检查
- 作者：K. Guo;G. Kasymjanova;H. Wang;L. Sakr;D. Small;V. Cohen;C. Pepe;A. Spatz;J. Agulnik
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
98.MS06.02 The Role of Interventional Pulmonology and Radiology

机译：MS06.02介入肺系统的作用
- 作者：K. Fong
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
99.P2.06-30 Association of Histopathological Patterns of Mesothelioma and Response to Treatment with Chemotherapy

机译：P2.06-30间皮瘤组织病理学模式和化疗治疗的响应
- 作者：J. Rodriguez-Cid;D. Bonilla-Molina;E.S. Pe?a Mirabal;J.A. Alatorre Alexander;L. Martínez Barrera;J.P. Díaz Rico;P. Santillan Doherty
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期
100.P3.16-23 Soft-Tissue Sarcoma of the Chest Wall, Surgical Resection: Analysis Our Cases Period of Time Decembre 2004-July 2017

机译：P3.16-23胸壁软组织肉瘤，手术切除：分析我们的案例时间段Decembre 2004-七月2017
- 作者：F. Gradica;D. Argjiri;L. Lisha;A. Cani;F. Kokici;I. Avdiu;H. Nino;Y. Vata;V. Rexha;S. Gradica
- 期刊名称：《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 | 2018年第10期

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号